Cargando…

Meier-Gorlin syndrome

Meier-Gorlin syndrome (MGS) is a rare autosomal recessive primordial dwarfism disorder, characterized by microtia, patellar applasia/hypoplasia, and a proportionate short stature. Associated clinical features encompass feeding problems, congenital pulmonary emphysema, mammary hypoplasia in females a...

Descripción completa

Detalles Bibliográficos
Autores principales: de Munnik, Sonja A., Hoefsloot, Elisabeth H., Roukema, Jolt, Schoots, Jeroen, Knoers, Nine VAM, Brunner, Han G., Jackson, Andrew P., Bongers, Ernie MHF
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574002/
https://www.ncbi.nlm.nih.gov/pubmed/26381604
http://dx.doi.org/10.1186/s13023-015-0322-x
_version_ 1782390547504168960
author de Munnik, Sonja A.
Hoefsloot, Elisabeth H.
Roukema, Jolt
Schoots, Jeroen
Knoers, Nine VAM
Brunner, Han G.
Jackson, Andrew P.
Bongers, Ernie MHF
author_facet de Munnik, Sonja A.
Hoefsloot, Elisabeth H.
Roukema, Jolt
Schoots, Jeroen
Knoers, Nine VAM
Brunner, Han G.
Jackson, Andrew P.
Bongers, Ernie MHF
author_sort de Munnik, Sonja A.
collection PubMed
description Meier-Gorlin syndrome (MGS) is a rare autosomal recessive primordial dwarfism disorder, characterized by microtia, patellar applasia/hypoplasia, and a proportionate short stature. Associated clinical features encompass feeding problems, congenital pulmonary emphysema, mammary hypoplasia in females and urogenital anomalies, such as cryptorchidism and hypoplastic labia minora and majora. Typical facial characteristics during childhood comprise a small mouth with full lips and micro-retrognathia. During ageing, a narrow, convex nose becomes more prominent. The diagnosis MGS should be considered in patients with at least two of the three features of the clinical triad of microtia, patellar anomalies, and pre- and postnatal growth retardation. In patients with short stature and/or microtia, the patellae should be assessed with care by ultrasonography before age 6 or radiography thereafter. Mutations in one of five genes (ORC1, ORC4, ORC6, CDT1, and CDC6) of the pre-replication complex, involved in DNA-replication, are detected in approximately 67-78 % of patients with MGS. Patients with ORC1 and ORC4 mutations appear to have the most severe short stature and microcephaly. Management should be directed towards in-depth investigation, treatment and prevention of associated problems, such as growth retardation, feeding problems, hearing loss, luxating patellae, knee pain, gonarthrosis, and possible pulmonary complications due to congenital pulmonary emphysema with or without broncho- or laryngomalacia. Growth hormone treatment is ineffective in most patients with MGS, but may be effective in patients in whom growth continues to decrease after the first year of life (usually growth velocity normalizes after the first year) and with low levels of IGF1. At present, few data is available about reproduction of females with MGS, but the risk of premature labor might be increased. Here, we propose experience-based guidelines for the regular care and treatment of MGS patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13023-015-0322-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4574002
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45740022015-09-19 Meier-Gorlin syndrome de Munnik, Sonja A. Hoefsloot, Elisabeth H. Roukema, Jolt Schoots, Jeroen Knoers, Nine VAM Brunner, Han G. Jackson, Andrew P. Bongers, Ernie MHF Orphanet J Rare Dis Review Meier-Gorlin syndrome (MGS) is a rare autosomal recessive primordial dwarfism disorder, characterized by microtia, patellar applasia/hypoplasia, and a proportionate short stature. Associated clinical features encompass feeding problems, congenital pulmonary emphysema, mammary hypoplasia in females and urogenital anomalies, such as cryptorchidism and hypoplastic labia minora and majora. Typical facial characteristics during childhood comprise a small mouth with full lips and micro-retrognathia. During ageing, a narrow, convex nose becomes more prominent. The diagnosis MGS should be considered in patients with at least two of the three features of the clinical triad of microtia, patellar anomalies, and pre- and postnatal growth retardation. In patients with short stature and/or microtia, the patellae should be assessed with care by ultrasonography before age 6 or radiography thereafter. Mutations in one of five genes (ORC1, ORC4, ORC6, CDT1, and CDC6) of the pre-replication complex, involved in DNA-replication, are detected in approximately 67-78 % of patients with MGS. Patients with ORC1 and ORC4 mutations appear to have the most severe short stature and microcephaly. Management should be directed towards in-depth investigation, treatment and prevention of associated problems, such as growth retardation, feeding problems, hearing loss, luxating patellae, knee pain, gonarthrosis, and possible pulmonary complications due to congenital pulmonary emphysema with or without broncho- or laryngomalacia. Growth hormone treatment is ineffective in most patients with MGS, but may be effective in patients in whom growth continues to decrease after the first year of life (usually growth velocity normalizes after the first year) and with low levels of IGF1. At present, few data is available about reproduction of females with MGS, but the risk of premature labor might be increased. Here, we propose experience-based guidelines for the regular care and treatment of MGS patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13023-015-0322-x) contains supplementary material, which is available to authorized users. BioMed Central 2015-09-17 /pmc/articles/PMC4574002/ /pubmed/26381604 http://dx.doi.org/10.1186/s13023-015-0322-x Text en © de Munnik et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
de Munnik, Sonja A.
Hoefsloot, Elisabeth H.
Roukema, Jolt
Schoots, Jeroen
Knoers, Nine VAM
Brunner, Han G.
Jackson, Andrew P.
Bongers, Ernie MHF
Meier-Gorlin syndrome
title Meier-Gorlin syndrome
title_full Meier-Gorlin syndrome
title_fullStr Meier-Gorlin syndrome
title_full_unstemmed Meier-Gorlin syndrome
title_short Meier-Gorlin syndrome
title_sort meier-gorlin syndrome
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574002/
https://www.ncbi.nlm.nih.gov/pubmed/26381604
http://dx.doi.org/10.1186/s13023-015-0322-x
work_keys_str_mv AT demunniksonjaa meiergorlinsyndrome
AT hoefslootelisabethh meiergorlinsyndrome
AT roukemajolt meiergorlinsyndrome
AT schootsjeroen meiergorlinsyndrome
AT knoersninevam meiergorlinsyndrome
AT brunnerhang meiergorlinsyndrome
AT jacksonandrewp meiergorlinsyndrome
AT bongerserniemhf meiergorlinsyndrome